Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Aug 6;93(16):8558–8562. doi: 10.1073/pnas.93.16.8558

Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+mice.

N Hosaka 1, M Nose 1, M Kyogoku 1, N Nagata 1, S Miyashima 1, R A Good 1, S Ikehara 1
PMCID: PMC38711  PMID: 8710909

Abstract

MRL/MP-+/+ (MRL/+) mice develop pancreatitis and sialoadenitis after they reach 7 months of age. Conventional bone marrow transplantation has been found to be ineffective in the treatment of these forms of apparent autoimmune disease. Old MRL/+ mice show a dramatic thymic involution with age. Hematolymphoid reconstitution is incomplete when fetal liver cells (as a source of hemopoietic stem cells) plus fetal bone (FB; which is used to recruit stromal cells) are transplanted from immunologically normal C57BL/6 donor mice to MRL/+ female recipients. Embryonic thymus from allogeneic C57BL/6 donors was therefore engrafted along with either bone marrow or fetal hematopoietic cells (FHCs) plus fragments of adult or fetal bone. More than seventy percent of old MRL/+ mice (> 7 months) that had been given a fetal thymus (FT) transplant plus either bone marrow or FHCs and also bone fragments survived more than 100 days after treatment. The mice that received FHCs, FB, plus FT from allogeneic donors developed normal T cell and B cell functions. Serum amylase levels decreased in these mice whereas they increased in the mice that received FHCs and FB but not FT. The pancreatitis and sialoadenitis already present at the time of transplantations were fully corrected according to histological analysis by transplants of allogeneic FHCs, FB and FT in the MRL/+ mice. These findings are taken as an experimental indication that perhaps stem cell transplants along with FT grafts might represent a useful strategy for treatment of autoimmune diseases in aged humans.

Full text

PDF
8558

Images in this article

8560Fig. 4
on p.8560
8561Fig. 5
on p.8561

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson K., Storb R., Ochs H. D., Goehle S., Sullivan K. M., Witherspoon R. P., Lum L. G., Tsoi M. S., Sanders J. E., Parr M. Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans. Transplantation. 1982 Feb;33(2):168–173. doi: 10.1097/00007890-198202000-00012. [DOI] [PubMed] [Google Scholar]
  2. Hirschhorn R., Vawter G. F., Kirkpatrick J. A., Jr, Rosen F. S. Adenosine deaminase deficiency: frequency and comparative pathology in autosomally recessive severe combined immunodeficiency. Clin Immunol Immunopathol. 1979 Sep;14(1):107–120. doi: 10.1016/0090-1229(79)90131-4. [DOI] [PubMed] [Google Scholar]
  3. Ikehara S., Good R. A., Nakamura T., Sekita K., Inoue S., Oo M. M., Muso E., Ogawa K., Hamashima Y. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A. 1985 Apr;82(8):2483–2487. doi: 10.1073/pnas.82.8.2483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ikehara S., Ohtsuki H., Good R. A., Asamoto H., Nakamura T., Sekita K., Muso E., Tochino Y., Ida T., Kuzuya H. Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7743–7747. doi: 10.1073/pnas.82.22.7743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ikehara S., Yasumizu R., Inaba M., Izui S., Hayakawa K., Sekita K., Toki J., Sugiura K., Iwai H., Nakamura T. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A. 1989 May;86(9):3306–3310. doi: 10.1073/pnas.86.9.3306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ishida T., Inaba M., Hisha H., Sugiura K., Adachi Y., Nagata N., Ogawa R., Good R. A., Ikehara S. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol. 1994 Mar 15;152(6):3119–3127. [PubMed] [Google Scholar]
  7. Kanno H., Nose M., Itoh J., Taniguchi Y., Kyogoku M. Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism. Clin Exp Immunol. 1992 Jul;89(1):68–73. doi: 10.1111/j.1365-2249.1992.tb06879.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Klingemann H. G., Storb R., Fefer A., Deeg H. J., Appelbaum F. R., Buckner C. D., Cheever M. A., Greenberg P. D., Stewart P. S., Sullivan K. M. Bone marrow transplantation in patients aged 45 years and older. Blood. 1986 Mar;67(3):770–776. [PubMed] [Google Scholar]
  9. Kumamoto T., Inaba M., Toki J., Adachi Y., Imamura H., Ikehara S. Cytotoxic effects of irradiation and deoxyguanosine on fetal thymus. Immunobiology. 1995 Apr;192(5):365–381. doi: 10.1016/S0171-2985(11)80176-2. [DOI] [PubMed] [Google Scholar]
  10. Mayumi M., Kimata H., Suehiro Y., Hosoi S., Ito S., Kuge Y., Shinomiya K., Mikawa H. DiGeorge syndrome with hypogammaglobulinaemia: a patient with excess suppressor T cell activity treated with fetal thymus transplantation. Eur J Pediatr. 1989 Apr;148(6):518–522. doi: 10.1007/BF00441546. [DOI] [PubMed] [Google Scholar]
  11. Nakagawa T., Nagata N., Hosaka N., Ogawa R., Nakamura K., Ikehara S. Prevention of autoimmune inflammatory polyarthritis in male New Zealand black/KN mice by transplantation of bone marrow cells plus bone (stromal cells). Arthritis Rheum. 1993 Feb;36(2):263–268. doi: 10.1002/art.1780360220. [DOI] [PubMed] [Google Scholar]
  12. Oyaizu N., Yasumizu R., Miyama-Inaba M., Nomura S., Yoshida H., Miyawaki S., Shibata Y., Mitsuoka S., Yasunaga K., Morii S. (NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura. J Exp Med. 1988 Jun 1;167(6):2017–2022. doi: 10.1084/jem.167.6.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Phan D. T., Phuong D. T., An V. T., Khue P., Petrányi G. G., Hollán S. R. Effect of thymus transplantation on the number of granulocytes, antibody forming cells and on the life-span of aged mice. Thymus. 1987;9(2):123–125. [PubMed] [Google Scholar]
  14. Ringdén O., Nilsson B. Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy. Transplantation. 1985 Jul;40(1):39–44. doi: 10.1097/00007890-198507000-00009. [DOI] [PubMed] [Google Scholar]
  15. Weiner R. S., Bortin M. M., Gale R. P., Gluckman E., Kay H. E., Kolb H. J., Hartz A. J., Rimm A. A. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med. 1986 Feb;104(2):168–175. doi: 10.7326/0003-4819-104-2-168. [DOI] [PubMed] [Google Scholar]
  16. Yasumizu R., Sugiura K., Iwai H., Inaba M., Makino S., Ida T., Imura H., Hamashima Y., Good R. A., Ikehara S. Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue. Proc Natl Acad Sci U S A. 1987 Sep;84(18):6555–6557. doi: 10.1073/pnas.84.18.6555. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES